Evidence map›Paper›PMID 39814722›Full record

ArticleNature communications2025

The Toxoplasma rhoptry protein ROP55 is a major virulence factor that prevents lytic host cell death.

Margarida T Grilo Ruivo, Ji-Hun Shin, Todd Lenz, Stephanie Y Matsuno, Katherine Olivia Yanes, Arnault Graindorge, Maguy Hamie, Laurence Berry-Sterkers, Mathieu Gissot, Hiba El Hajj and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. ROP64-DeficientMicroorganisms · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Margarida T Grilo RuivoLaboratory of Pathogens and Host Immunity, UMR 5294 CNRS, UA15 INSERM, Université de Montpellier, Montpellier, 34095, France.ORCID http://orcid.org/0000-0001-8667-9250
Ji-Hun Shin *Department of Molecular Biology and Biochemistry and the Institute for Immunology, University of California, Irvine, CA, 92697, USA.
Todd Lenz *Department of Molecular, Cell and Systems Biology, University of California Riverside, Riverside, CA, 92521, USA.ORCID http://orcid.org/0000-0001-6209-7061
Stephanie Y MatsunoDepartment of Molecular Biology and Biochemistry and the Institute for Immunology, University of California, Irvine, CA, 92697, USA.ORCID http://orcid.org/0000-0003-0374-2395
Katherine Olivia YanesDepartment of Molecular Biology and Biochemistry and the Institute for Immunology, University of California, Irvine, CA, 92697, USA.
Arnault GraindorgeLaboratory of Pathogens and Host Immunity, UMR 5294 CNRS, UA15 INSERM, Université de Montpellier, Montpellier, 34095, France.ORCID http://orcid.org/0000-0002-6076-3646
Maguy HamieDepartment of Experimental Pathology, Immunology and Microbiology, American University of Beirut, Beirut, Lebanon.
Laurence Berry-SterkersLaboratory of Pathogens and Host Immunity, UMR 5294 CNRS, UA15 INSERM, Université de Montpellier, Montpellier, 34095, France.
Mathieu GissotU1019 - UMR 9017, Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, F-59000, France.ORCID http://orcid.org/0000-0003-0047-8189
Hiba El HajjDepartment of Experimental Pathology, Immunology and Microbiology, American University of Beirut, Beirut, Lebanon.ORCID http://orcid.org/0000-0002-1069-0477
Karine G Le RochDepartment of Molecular, Cell and Systems Biology, University of California Riverside, Riverside, CA, 92521, USA.ORCID http://orcid.org/0000-0002-4862-9292
Melissa B LodoenDepartment of Molecular Biology and Biochemistry and the Institute for Immunology, University of California, Irvine, CA, 92697, USA.
Maryse LebrunLaboratory of Pathogens and Host Immunity, UMR 5294 CNRS, UA15 INSERM, Université de Montpellier, Montpellier, 34095, France. maryse.lebrun@umontpellier.fr.ORCID http://orcid.org/0000-0002-0962-0156
Diana Marcela Penarete-VargasLaboratory of Pathogens and Host Immunity, UMR 5294 CNRS, UA15 INSERM, Université de Montpellier, Montpellier, 34095, France. diana.penarete-vargas@umontpellier.fr.ORCID http://orcid.org/0000-0002-3306-3943

Funding

Chromatin structure and control of gene expression in the human malaria parasiteR01AI136511 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LE ROCH, KARINE GAELLE · 2018 to 2022
$3.4M
Parasite dissemination in Toxoplasmic encephalitisR01AI120846 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI LODOEN, MELISSA BRUCKNER · 2016 to 2020
$2.0M
T32 for Training in Microbiology & Infectious DiseasesT32AI141346 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Celia Goulding, Melissa Bruckner Lodoen · 2019 to 2026
$1.0M
Evolution of the 3D chromatin structure in apicomplexan parasitesR21AI142506 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LE ROCH, KARINE GAELLE · 2019 to 2020
$479k
Role of caspase-8 in innate immunity to infectionR21AI156452 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI LODOEN, MELISSA BRUCKNER · 2021 to 2022
$396k
NIAID NIH HHS R01 AI120846NIAID NIH HHS R01 AI136511NIAID NIH HHS R21 AI142506NIAID NIH HHS R21 AI156452NIAID NIH HHS T32 AI141346UC | University of California, Riverside (UC Riverside) NIFA-Hatch-225935U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI120846 and R21AI156452U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI136511 and R21 AI142506
6 · The paper itself

Abstract

Programmed-cell death is an antimicrobial defense mechanism that promotes clearance of intracellular pathogens. Toxoplasma counteracts host immune defenses by secreting effector proteins into host cells; however, how the parasite evades lytic cell death and the effectors involved remain poorly characterized. We identified ROP55, a rhoptry protein that promotes parasite survival by preventing lytic cell death in absence of IFN-γ stimulation. RNA-Seq analysis revealed that ROP55 acts as a repressor of host pro-inflammatory responses. In THP-1 monocytes ΔROP55 infection increased NF-κB p65 nuclear translocation, IL-1β production, and GSDMD cleavage compared to wild type or complemented parasites. ΔROP55 infection also induced RIPK3-dependent necroptosis in human and mouse primary macrophages. Moreover, ΔROP55 parasites were significantly impaired in virulence in female mice and prevented NF-κB activation and parasite clearance in mBMDM. These findings place ROP55 as a major virulence factor, dampening lytic cell death and enabling Toxoplasma to evade clearance from infected cells.

Indexed as

Protozoan ProteinsToxoplasmaToxoplasmosisVirulence FactorsAnimalsCell DeathFemaleHost-Parasite InteractionsHumansInterleukin-1betaMacrophagesMiceMice, Inbred C57BLNecroptosisNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesInterleukin-1betaNF-kappa BProtozoan ProteinsReceptor-Interacting Protein Serine-Threonine KinasesTranscription Factor RelAVirulence Factors

Identifiers

PMID39814722
PMCPMC11736080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.